HPV vaccines for prevention of cervical pre-cancer in adolescent girls and women
The evidence presented in this Cochrane meta-analysis shows the HPV vaccination confers significant benefit in preventing cervical pre-cancer. NNT of 60 for preventing one cervical pre-cancer (women 15 to 25 years old with or without HPV infection). The effect is higher for lesions associated with H...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Escola Bahiana de Medicina e Saúde Pública
2019-10-01
|
| Series: | Journal of Evidence-Based Healthcare |
| Subjects: | |
| Online Access: | https://www5.bahiana.edu.br/index.php/evidence/article/view/2510 |
| Summary: | The evidence presented in this Cochrane meta-analysis shows the HPV vaccination confers significant benefit in preventing cervical pre-cancer. NNT of 60 for preventing one cervical pre-cancer (women 15 to 25 years old with or without HPV infection). The effect is higher for lesions associated with HPV16/18. The data also demonstrates an absence of serious adverse events. Therefore, we have assigned a color recommendation of Green (Benefit > Harm) to this vaccine. |
|---|---|
| ISSN: | 2675-021X |